Back to News
Market Impact: 0.43

Earnings call transcript: Camtek Q1 2026 beats forecasts, stock drops By Investing.com

CAMTBACMSOPYEVRSMCIAPP
Corporate EarningsCorporate Guidance & OutlookArtificial IntelligenceTechnology & InnovationCompany FundamentalsAnalyst EstimatesProduct LaunchesCurrency & FX
Earnings call transcript: Camtek Q1 2026 beats forecasts, stock drops By Investing.com

Camtek beat Q1 2026 expectations with revenue of $121.7 million versus $119.71 million consensus and EPS of $0.70 versus $0.69, but shares fell 7.38% pre-market as operating margin compressed to 25.5% from 31.5% year over year. Management guided Q2 revenue to $129 million-$131 million and said margins should improve in 2H 2026, supported by AI-related products that represented 50% of sales and strong demand for Eagle G5 and Hawk.

Analysis

The read-through is less about one quarter and more about an accelerating revenue mix shift in advanced packaging metrology/inspection. The key second-order effect is that Camtek is becoming more levered to a narrower set of AI/HBM customers while simultaneously investing ahead of demand; that tends to compress near-term margins but raises the probability of multiple expansion if conversion of backlog is clean into 2H and 2027. The market’s negative reaction looks like a classic “quality beat but guide-mix disappointment” setup, where investors are discounting the expense spike before the operating leverage shows up. The bigger implication for the ecosystem is that AI packaging capex is now propagating from front-end spend into adjacent test/inspection pockets with a lag, which should benefit a small set of niche equipment vendors before it shows up broadly in the SEMI cycle. Camtek’s installed-base software monetization is the real hidden upside: if AI upgrades can be layered onto the existing fleet, incremental revenue could carry much higher gross margin than hardware and partially offset FX pressure. That also creates a potential competitive moat versus larger peers that may be slower to productize software-led differentiation. The risk is timing, not thesis. If customer acceptance or shipment scheduling slips by even one quarter, the current valuation leaves little room for execution misses; conversely, if 2H revenue ramps as advertised, the stock can re-rate quickly because the market is currently anchoring on depressed near-term margins rather than 2027 earnings power. The contrarian point: the selloff may be overdone if the company truly has visibility into incremental orders beyond the disclosed backlog, but underdone if the AI/software attach turns out to be mostly narrative and not monetizable within 6-9 months.